# Jiangsu Yuyue Medical Equipment & Supply

Jiangsu Yuyue Medical Equipment & Supply is a Corporate Investor based in Danyang, China.

## Overview

- **Organization type:** Corporate Investor
- **Headquarters:** Danyang, China
- **Region:** Asia
- **Address:** No. 1 Baisheng Road, Development Zone, Danyang, Jiangsu, China
- **Founded:** 1998
- **Assets under management:** Undisclosed
- **Website:** www.yuwell.com
- **LinkedIn:** https://www.linkedin.com/company/%e9%b1%bc%e8%b7%83%e5%8c%bb%e7%96%97

## Regulatory record

- **Reports private funds:** No

## About

Jiangsu Yuyue Medical Equipment & Supply was established in 1998 in Danyang, Jiangsu, by Wu Guangming to make blood-pressure monitors and other home-care devices affordable across China's emerging consumer-healthcare market. The company listed on the Shenzhen Stock Exchange (SZ: 002223) and grew into one of China's largest domestic medical-device manufacturers, with a product catalog spanning oxygen concentrators, nebulizers, and pulse oximeters. The founding family retains control through Wu Qun, who succeeded his father as chairman and CEO, while the broader board includes figures from Chinese academia and state-linked healthcare networks. The firm deploys capital through two lanes: in-house R&D and manufacturing scale-ups within its core respiratory and chronic-disease categories, and external minority investments in healthcare startups via its strategic investment arm. Asset classes include private equity, venture capital, and direct operating assets. It co-invests alongside technology conglomerates and venture funds — Tencent participated in a round for Yuwell's internet-health subsidiary Xunjie Medical, and Sequoia Capital China has partnered on healthcare deals. Geographically, Yuwell sells into Southeast Asia, South Asia, the Middle East, and Africa through a network of distributors, supplementing its dominant position inside China. Beyond its Danyang production campus, Yuwell operates commercial headquarters in Nanjing and Shanghai and maintains global R&D centers. The group controls a private jet for executive travel and holds the chairmanship of the Chinese Medical Equipment Industry Association, signaling policy-level influence. In September 2023, the company reported a restructuring of its hypertension and respiratory product lines under a single chronic-disease management unit, reflecting a pivot toward integrated care bundles rather than standalone hardware sales. The firm's structural differentiator is vertical integration between a state-listed manufacturing flow and a venture book that feeds on the manufacturing arm's distributor relationships. Rather than competing as a pure financial investor, Yuwell offers portfolio companies accelerated regulatory navigation through CFDA/NMPA processes and immediate shelf space inside China's tier-2 and tier-3 hospital procurement systems — a bundling of capital and commercialization that conventional VC funds cannot replicate.

## Sectors

- Healthcare Services
- Digital Health
- Industrial Tech

## Offices

- Nanjing, Jiangsu, China
- Shanghai, China

## People

- Wu Qun — Chairman and CEO
- Wu Guangming — Founder

## Questions

### Does Yuwell operate a dedicated venture fund?

No dedicated venture fund is publicly disclosed. Yuwell invests via its corporate balance sheet and operates Xunjie Medical, a subsidiary focused on smart respiratory devices, which received strategic investment from Tencent. All known deployment is direct rather than through a separate limited partnership structure.

### What healthcare subsectors does Yuwell target for investment?

Yuwell concentrates on homecare medtech, including respiratory care and chronic disease management devices. The firm also backs digital health ventures that connect diagnostic hardware to telemedicine platforms, reflecting the parent company's existing expertise in oxygen concentrators and blood pressure monitors.

### How is Yuwell related to Xunjie Medical?

Xunjie Medical is a subsidiary of Yuwell focused on internet-connected respiratory care devices. Tencent became a strategic investor in Xunjie Medical, making it a key vehicle for Yuwell's digital health push while the parent company retains operational control.

### What is Yuwell's approach to manufacturing versus investment?

Yuwell treats venture investment as an extension of its manufacturing ecosystem, not a standalone financial activity. Capital deployment often takes the form of direct subsidiary creation or strategic enterprise investment that simultaneously secures technology access, supply-chain coverage, and channel expansion for core device product lines.

## Related profiles

- [Jiangsu Yusujing Information Technology](https://altss.com/profile/jiangsu-yusujing-information-technology)
- [Jiangsu Yuyue Science & Technology Development](https://altss.com/profile/jiangsu-yuyue-science-technology-development)

---

Last updated: 2026-07-06T00:35:01.127Z

Canonical page: https://altss.com/profile/jiangsu-yuyue-medical-equipment-supply

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology